Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

A crucial step for accelerating tuberculosis drug development is bridging the gap between preclinical and clinical trials. In this study, we developed a preclinical model‐informed translational approach to predict drug effects across preclinical systems and early clinical trials using the in vitro‐b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicha, Sebastian G., Clewe, Oskar, Svensson, Robin J., Gillespie, Stephen H., Hu, Yanmin, Coates, Anthony R.M., Simonsson, Ulrika S.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282494/
https://www.ncbi.nlm.nih.gov/pubmed/29700814
http://dx.doi.org/10.1002/cpt.1102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282494/
https://www.ncbi.nlm.nih.gov/pubmed/29700814
http://dx.doi.org/10.1002/cpt.1102

Ejemplares similares